NCT00031863 2013-08-02Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal CancerNational Cancer Institute (NCI)Phase 3 Completed
NCT00164892 2005-11-17Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled TrialChinese University of Hong KongPhase 3 Unknown214 enrolled